Prime Minister, Scott Morrison launched the MS Australia 2019 Election Commitments package at a Parliamentary Friends of Multiple Sclerosis event, in the Senate Alcove, Parliament House, Canberra, on Thursday 29 November, 2018.
The MS Australia 2019 Election Commitments package sets out the nine important ways our Federal politicians can help people affected by multiple sclerosis (MS).
(Note: Due to the formatting of these 3 PDF documents, please choose "fit to page" or "fit" when printing.)
MS Australia, on behalf of the broader MS community, seeks commitments from all political parties and independents, to the nine initiatives
in these Roadmaps that will each make significant improvements for people living with MS in Australia.
There are now more than 25,600 Australians living with MS and over 7.6 million Australians who know or have a loved one with this potentially debilitating disease. MS is the most commonly acquired neurological disease in young adults, diagnosis is mostly between the ages of 20 and 40 and three quarters of those diagnosed are women. The economic impact of MS in Australia was $1.75 billion in 2017.*
"There is no known cause or single cure, but there is now an opportunity for this generation of political leaders and decision-makers to consign MS to a foot-note in history," said MS Australia CEO, Deidre Mackechnie.
"We need a concerted effort to provide improved support for the management and care of MS, through systemic improvements to the health care, disability care and aged care sectors," added Ms Mackechnie.
We are seeking commitments to:
Further details on how these improvements will be achieved is set out in the 2019 Election Commitments
and the three Roadmaps.
MS Australia, with the support of those living with MS in Australia, will pursue a commitment from all politicians to each of these improvements in the lead up to the 2019 Federal election.
* Source: The Health Economic Impact of Multiple Sclerosis in Australia 2017 report, commissioned by MS Research Australia and prepared by the Menzies Institute for Medical Research, University of Tasmania.